Abstract. Antimycin A (AMA) inhibits the mitochondrial electron transport between cytochromes b and c. However, the relationship between AMA and lung cancer cells is poorly understood. In this study, we investigated the involvement of reactive oxygen species (ROS) and glutathione (GSH) in AMA-treated lung cancer Calu-6 cell death. Treatment with AMA reduced cell viability in a dose-dependent manner for 72 h. The intracellular ROS levels were decreased in Calu-6 cells treated with low doses of AMA (10, 25 or 50 μM) at 72 h. However, the levels increased in cells treated with a high dose of 100 μM AMA. Levels of O 2
Introduction
Reactive oxygen species (ROS) include hydrogen peroxide (H 2 O 2 ), superoxide anion (O 2
•-) and hydroxyl radical ( • OH). These molecules have recently been implicated in regulating many important cellular events, including transcriptional factor activation, gene expression, differentiation and cell proliferation (1) (2) (3) . ROS are formed as by-products of mitochondrial respiration or the action of oxidases, including nicotine adenine diphosphate (NADPH), xanthine (XO) and certain arachidonic acid oxygenases (1) . A change in the redox state of a tissue implies a change in ROS generation or metabolism. The principal metabolic pathways include superoxide dismutase (SOD), which is expressed as extracellular, intracellular and mitochondrial isoforms. These isoforms metabolize O 2
•-to H 2 O 2 . Further metabolism by peroxidases, which include catalase and glutathione (GSH), yields O 2 and H 2 O (4). GSH is the main non-protein antioxidant in the cell and provides electrons for enzymes such as glutathione peroxidase, which reduce H 2 O 2 to H 2 O. GSH has been shown to be crucial for cell proliferation, cell cycle progression and apoptosis (5, 6) and is known to protect cells from toxic insult by detoxifying toxic metabolites of drugs and ROS (7) . Although cells possess antioxidant systems to control their redox state, which is important for their survival, excessive ROS production can be induced and give rise to the activation of events that lead to death or survival in different cell types (2, (8) (9) (10) (11) . The exact mechanisms involved in cell death induced by ROS are not fully understood and the protective effect of certain antioxidants remains controversial.
Antimycin A (AMA) is a product that is predominantly composed of antimycin A1 and A3, which are derived from Streptomyces kitazawensis (12) . AMA inhibits succinate and NADH oxidase, and inhibits the mitochondrial electron transport between cytochromes b and c (13) (14) (15) (16) . The inhibition of electron transport causes a collapse of the proton gradient across the mitochondrial inner membrane, thereby breaking down the mitochondrial membrane potential (ΔΨ m ) (13, 15, 17) . This inhibition results in ROS production (17, 18) . Evidence indicates that either the presence of ROS or the collapse of mitochondrial membrane potential (ΔΨ m ) opens the mitochondrial permeability transition pore, which is associated with the release of proapoptotic molecules such as cytochrome c into the cytoplasm (19) (20) (21) . Since AMA acts directly on the mitochondria, AMA-induced apoptosis has been reported in many experiments, including our report on As4.1 juxtaglomerular cells (22) (23) (24) (25) (26) (27) .
Lung cancer is the major cause of cancer death in developed countries. There are various novel therapeutic strategies currently under consideration, as the clinical use of cytotoxic drugs is limited due to intrinsic or acquired resistance and toxicity (28) . A better understanding of the molecular mechanisms of cytotoxic drug action has shed light on the treatment of lung cancer, and novel agents that target specific intracellular pathways related to the distinctive properties of cancer cells continue to be developed. Specifically, research on mitochondrial damage agents including AMA in lung cancer cells would inform the new drug development about the treatment of lung cancer patients.
In the present study, we assessed the involvement of ROS and GSH in AMA-induced Calu-6 cell death and investigated whether ROS scavengers rescue these cells from AMAinduced cell death.
Materials and methods
Cell culture. A human pulmonary adenocarcinoma Calu-6 cell line was obtained from the ATCC and maintained in a humidified incubator with 5% CO 2 at 37˚C. The cells were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Gibco BRL, Grand Island, NY). They were routinely grown in 100-mm plastic tissue culture dishes (Nunc, Roskilde, Denmark) and harvested with a solution of trypsin-EDTA while in the logarithmic phase. Cells were maintained in these culture conditions for all experiments.
Reagents. AMA was purchased from Sigma-Aldrich Chemical Company (St. Louis, MO). AMA was dissolved in ethanol at 200 mM as a stock solution. The cell-permeable O 2
•-scavengers, 4-hydroxy-TEMPO (4-hydroxyl-2,2,6,6-tetramethylpierydine-1-oxyl) (tempol), 4,5-dihydroxyl-1,3-benzededisulfonic acid (tiron) and 1-[2,3,4-trimethoxibenzyl]-piperazine (trimetazidine) were obtained from Sigma. These were dissolved in water or ethanol solution buffer at 100 mM as a stock solution, which was also used as a control vehicle. SOD and catalase were obtained from Sigma and dissolved in 50 mM potassium phosphate buffer at 4733 U/ml. The stock solution was wrapped in foil and kept at 4˚C or -20˚C.
Cell viability assay. The cell viability effect of AMA on Calu-6 cells was determined by measuring the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye absorbance of living cells as described previously (29) . In brief, cells (5x10 4 /well) were seeded in 96-well microtiter plates in the presence of the designated doses of AMA with or without scavenger (tempol, tiron or trimetazidine). After exposure to AMA for 72 h, 50 μl of MTT (Sigma) solution (2 mg/ml in PBS) were added to each well, and the plates were incubated for an additional 3 h at 37˚C. MTT solution in medium was aspirated off. To achieve solubilization of the formazan crystals formed in viable cells, 200 μl of DMSO were added to each well. The optical density of each well was measured at 570 nm using a microplate reader (Spectra MAX 340, Molecular Devices Co., Sunnyvale, CA, USA). Each plate contained multiple wells at a given experimental condition and multiple control wells. This procedure was replicated for 2-4 plates/condition.
Measurement of intracellular non-specific ROS and O 2
•-concentration. Intracellular non-specific ROS such as H 2 O 2 , • OH and ONOO
• were detected by means of the oxidationsensitive fluorescent probe dye, 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) (Invitrogen Molecular Probes, Eugene, OR). H 2 DCFDA was deacetylated intracellularly by non-specific esterase, which was then oxidized by cellular peroxides, yielding 2,7-dichlorofluorescein (DCF), a fluorescent compound (Ex/Em = 495/529 nm). DCF is poorly selective for the superoxide anion radical (O 2
•-). In contrast, dihydroethidium (DHE) (Ex/Em = 518/605 nm) (Invitrogen Molecular Probes) is a fluorogenic probe that is highly selective for O 2
•-among ROS. It is cell-permeable and reacts with superoxide anion to form ethidium, which in turn intercalates in the deoxyribonucleic acid, thereby exhibiting a red fluorescence. In brief, 1x10 6 cells were incubated with the designated doses of AMA with or without ROS scavenger (tempol, tiron, trimetazidine, SOD or catalase) for 72 h. They were then washed in PBS and incubated with 20 μM H 2 DCFDA or 5 μM DHE at 37˚C for 30 min. DCF fluorescence and red fluorescence were detected using a FACStar flow cytometer (Becton-Dickinson). For each sample, 10,000 events were collected. ROS and O 2
•-levels were expressed as mean fluorescence intensity (MFI), which was calculated by CellQuest software.
Measurement of cellular catalase activity. The level of cellular catalase enzyme activity was measured using a catalase assay kit from Sigma-Aldrich Chemical Company. In brief, 1x10 6 cells were incubated with 50 μM AMA for 1 or 72 h. The cells were washed with PBS and suspended in 5 volumes of lysis buffer [20 mM HEPES (pH 7.9), 20% glycerol, 200 mM KCl, 0.5 mM EDTA, 0.5% NP40, 0.5 mM DTT and 1% protease inhibitor cocktail (from Sigma)]. The lysates were then collected and stored at -20˚C until further use. The supernatant protein concentration was determined by the Bradford method. Supernatant samples containing 30 μg of total protein were used to determine catalase enzyme activity. These were added to a microcentrifuge tube with the appropriate volume of assay buffer (50 mM KH 2 PO 4 /50 mM Na 2 HPO 4 , pH 7.0). The reaction was initiated by the addition of 200 mM H 2 O 2 solution at 25˚C for 5 min, and was finished by the addition of stop solution. A small amount of the above reaction mixture was removed, added to another microcentrifuge tube with the color reagent (150 mM potassium phosphate buffer, pH 7.0, containing 0.25 mM 4-aminoantipyrine, 2 mM 3,5-dichloro-2-hydroxybenzenesulfonic acid and the peroxidase solution), and were incubated to convert the color reagent to a red quinoneimine color at 25˚C for ~10 min. The dye was measured at 520 nM using a microplate reader (Spectra MAX 340, Molecular Devices Co.). A standard curve of catalase solution (5 U-50 U/ml) was run for quantification.
Measurement of cellular SOD activity.
The level of cellular SOD enzyme activity was measured using a SOD Assay Kit-WST (Fluka Co, Milwaukee, WI, USA), which allows very convenient SOD assaying by utilizing a highly water-soluble tetrazolium salt, WST-1 (2-(4-lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium and monosodium salt), which produces a water-soluble formazan dye upon reduction with a superoxide anion. In brief, 1x10 6 cells were incubated with 50 μM AMA for 1 or 72 h. The cells were washed in PBS and suspended in 5 volumes of lysis buffer [20 mM HEPES (pH 7.9), 20% glycerol, 200 mM KCl, 0.5 mM EDTA, 0.5% NP40, 0.5 mM DTT and 1% protease inhibitor cocktail (from Sigma)]. The lysates were then collected and stored at -20˚C until further use. The supernatant protein concentration was determined by the Bradford method. Supernatant samples containing 30 μg of total protein were used to determine SOD enzyme activity. These were added to each well in 96-well microtiter plates (Nunc) with WST and enzyme working solution, and were incubated to produce a water-soluble formazan dye at 25˚C for 10 min. The WST-1 formazan was measured at 450 nM using a microplate reader (Spectra MAX 340, Molecular Devices Co.). A standard curve of SOD solution (5 U-50 U/ml) was run for quantification.
Detection of the intracellular glutathione (GSH).
Cellular GSH levels were analyzed using 5-chloromethylfluorescein diacetate (CMFDA, Molecular Probes). CMFDA (Ex/Em = 492/517 nm) is a membrane-permeable dye (30, 31) . In brief, 1x10 6 cells were incubated with 50 μM AMA with or without ROS scavenger (tempol, tiron, trimetazidine, SOD or catalase) for 72 h. They were then washed with PBS and incubated with 5 μM CMFDA at 37˚C for 30 min. Cytoplasmic esterases convert non-fluorescent CMFDA to fluorescent 5-chloromethylfluorescein, which reacts with glutathione. To verify the disruption of the plasma membrane in these cells, propidium iodide (PI 1 μg/ml; Ex/Em = 488/ 617 nm; Sigma-Aldrich) was added. CMF fluorescence and PI staining intensity were measured using a FACStar flow cytometer (Becton-Dickinson) and CellQuest software. For each sample, 10,000 events were collected.
Sub-G1 analysis. The amount of sub-G1 cells was determined by staining DNA with PI as described previously (32) . PI is a fluorescent biomolecule that stains DNA. In brief, 1x10 6 cells were incubated with 50 μM AMA with or without ROS scavengers (tempol, tiron or trimetazidine) for 72 h. They were then washed with phosphate-buffered saline (PBS) and fixed in 70% ethanol. They were washed again with PBS and incubated with PI (10 μg/ml) with the simultaneous treatment of RNase at 37˚C for 30 min. The percent of cells containing sub-G1 DNA content was measured using a FACStar flow cytometer (Becton-Dickinson) and analyzed with lysis II and CellFIT software (Becton-Dickinson).
Annexin V staining. Apoptosis was determined by staining cells with annexin V-fluorescein isothiocyanate (FITC) (Ex/Em = 495/529 nm), because annexin V is used to measure the externalization of phosphatidylserine during apoptosis and, detects cells in the early phases of apoptosis. Cells (1x10 6 ) were incubated with 50 μM AMA with or without ROS scavenger (tempol, tiron, trimetazidine, SOD or catalase) for 72 h. They were washed twice with cold PBS and resuspended in 500 μl of binding buffer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 ) at 1x10 6 cells/ml. Annexin V-FITC (5 μl) (PharMingen, USA) was then added to these cells, which were analyzed with a FACStar flow cytometer (Becton-Dickinson).
Measurement of mitochondrial membrane potential (ΔΨ m
). The mitochondrial membrane potential was monitored using Rhodamine 123 (Ex/Em = 507/529 nm), a cell-permeable cationic dye that preferentially enters mitochondria due to the highly negative mitochondrial membrane potential (ΔΨ m ). Depolarization of the mitochondrial membrane potential (ΔΨ m ) results in loss of Rhodamine 123 from the mitochondria and a decrease in intracellular fluorescence. Cells (1x10 6 ) were incubated with 50 μM AMA with or without ROS scavenger (tempol, Trion, trimetazidine, SOD or catalase) for 72 h. They were washed twice with PBS and incubated with Rhodamine 123 [0.1 (g/ml; Sigma)] at 37˚C for 30 min. Rhodamine 123 staining intensity was determined by flow cytometry.
Statistical analysis.
The results presented the were means of at least three independent experiments; bar, SD. Microsoft Excel or Instat software (GraphPad Prism4, USA) was used to analyze the data. Student's t-test or one-way analysis of variance (ANOVA), with post hoc analysis using Tukey's multiple comparison test, was used for parametric data. Statistical significance was defined as P<0.05.
Results

AMA effect on cell viability, intracellular ROS and GSH levels in Calu-6 cells.
We examined the effect of AMA on the viability of Calu-6 cells using MTT assay. Treatment with AMA reduced the cell viability in a dose-dependent manner for 72 h (Fig. 1A) . The viability was completely decreased at 100 μM of AMA (Fig. 1A) . To assess levels of intracellular non-specific ROS in AMA-treated Calu-6 cells, we used H 2 DCFDA fluorescence. As shown in Fig. 1B , the intracellular ROS levels decreased in Calu-6 cells treated with low doses of AMA (10, 25 or 50 μM) at 72 h. However, the levels in cells treated with a high dose of 100 μM AMA increased. The increased patterns of ROS levels by AMA were clearly detected within 10 min (Fig. 1C) and an increase in ROS levels lasted until the tested time of 5 h. Maximum levels of ROS were reached at ~180 min after treatment with 250 μM AMA. Intracellular O 2
•-levels increased in the AMA-treated Calu-6 cells in a dose-dependent manner at 72 h (Fig. 1D) . The level of the intracellular O 2
•-in Calu-6 cells treated with 100 μM AMA increased ~3.5 times, as compared to that of the control cells (Fig. 1D) . In addition, the accumulation of O 2
•-was observed at an early time point of 10 min in AMA-treated cells (Fig. 1E) . The maximum level of O 2
•-was reached at ~60 min after treatment with 70 μM AMA and was 15 times higher than that of the control cells. The levels then decreased after ~60 min. Fig. 2A , SOD activity was decreased in 50 μM AMA-treated cells at the early time phase of 1 h, but was increased at the later time phase of 72 h, as compared with that from the control cells. Conversely, treatment with AMA increased catalase activity at 1 h but decreased the activity at 72 h (Fig. 2B) .
We analyzed changes of the GSH level in Calu-6 cells using CMF fluorescence. The M1 population of Calu-6 cells showed the lower levels of the intracellular GSH content (Fig. 3A) . AMA significantly elevated the percentages of Calu-6 cells residing in the M1 region in a dose-dependent manner at 72 h (Fig. 3A) , pointing to the depletion of intracellular GSH in Calu-6 cells following treatment with AMA. Decrease of the intracellular GSH content (mean CMF fluorescence) was also observed at the early time points of 25 or 50 min in 70 or 250 μM AMA-treated cells (data not shown). We stained these cells with PI to verify the disruption of the plasma membrane. As shown in Fig. 3B , many CMF-negative cells treated with 100 μM AMA for 72 h were PI positive, indicating that the cells showing GSH depletion were dead. The proportion of CMF-negative and PI-positive cells increased in a dose-dependent manner (Fig. 3B) .
Effects of ROS scavengers on ROS, GSH levels and cell viability in AMA-treated Calu-6 cells.
To determine whether ROS levels and GSH depletion in AMA-treated Calu-6 cells are changed by ROS scavengers, cell-permeable ROS scavengers, tempol or tiron (33) (34) (35) , were co-incubated with AMA-treated Calu-6 cells for 72 h. An anti-ischemic and metabolic agent, trimetazidine was also used as an indirect antioxidant (36, 37) . We used 50 μM AMA for these experiments because 100 μM AMA induced cell death. As shown in Fig. 4A , the ROS level in AMA-treated cells was not significantly altered by 200 μM tempol or trimetazidine. However, treatment with 200 μM tiron significantly decreased the ROS level in these cells. Tempol and tiron significantly decreased the O 2 •-levels in AMA-treated cells but trimetazidine did not (Fig. 4B) . In addition, none of the scavengers prevented the depletion of GSH content in AMA-treated Calu-6 cells (Fig. 4C) . We did not use a higher concentration (>200 μM) of these scavengers due to their toxicity.
We then examined whether ROS scavengers rescue Calu-6 cells from AMA-induced cell death. Only tiron slightly recovered the viability of AMA-treated Calu-6 cells (Fig. 5A ) and decreased the number of sub-G1 and annexin V-positive cells in these cells (Fig. 5B and C) . Regarding the mitochondrial membrane potential (ΔΨ m ), tiron significantly prevented loss of the mitochondrial membrane potential (ΔΨ m ) in AMA-treated cells, while tempol and trimetazidine slightly prevented the loss (Fig. 5D ).
SOD and catalase effects on ROS, GSH levels and cell viability in AMA-treated Calu-6 cells.
To determine whether ROS levels and GSH depletion in AMA-treated Calu-6 cells are changed by treatment with exogenous SOD or catalase, Calu-6 cells were treated with AMA in the presence or absence of SOD (30 U/ml) or catalase (30 U/ml) for 72 h. As shown in Fig. 6A and B, SOD or catalase did not change the ROS levels including intracellular O 2
•-levels in AMA-treated Calu-6 cells, nor did they prevent the depletion of GSH content in Calu-6 cells treated with AMA (Fig. 6C) .
We examined whether SOD or catalase protects Calu-6 cells against AMA insult. They slightly increased the viability of AMA-treated Calu-6 cells (Fig. 6D) . Treatment with SOD or catalase did not decrease the number of annexin Vpositive staining cells induced by AMA (Fig. 6E) . However, SOD or catalase significantly reduced loss of the mitochondrial transmembrane potential (ΔΨ m ) in these cells (Fig. 6F) . When we used the amounts of SOD (60 U/ml) and catalase (60 U/ml) in the experiment, the dose showed no differences in ROS levels, GSH depletion and cell death in comparison with SOD (30 U/ml) and catalase (30 U/ml) (data not shown).
Discussion
In this study, we focused on the involvement of ROS and GSH in AMA-induced Calu-6 cell death and investigated whether ROS scavengers were able to rescue Calu-6 cells from AMA-induced apoptosis since we have previously observed that AMA inhibited the growth of Calu-6 cells by inducing a G1 arrest of the cell cycle and by triggering apoptosis (unpublished data).
AMA can disturb the natural oxidation/reduction equilibrium in cells by causing a breakdown in the mitochondrial membrane potential (ΔΨ m ) (13, 15, 17) . It is reported that the increased intracellular H 2 O 2 played an important role in AMA-induced cell death in liver (38,39) and A549 human lung cancer cells (18) . Similarly, treatment with 100 μM AMA strongly reduced the viability of Calu-6 cells and increased the non-specific ROS (DCF) level. An increase in intracellular ROS levels was also observed within 10 min in AMA-treated Calu-6 cells. These results suggest that the increased ROS levels by AMA are correlated with cell death. However, the intracellular ROS levels were decreased in Calu-6 cells treated with low doses of AMA (10, 25 or 50 μM) at 72 h. Tiron, which protected some Calu-6 cells against AMA insult, intensified the decreased levels of ROS in these cells. We have also recently reported that the increase of the intracellular ROS levels in AMA-treated As4.1 juxtaglomerular cells is not closely related to apoptosis (22) . Therefore, the exact cell death mechanism through the intracellular ROS in AMA-treated cells is controversial. AMA inhibits succinate and NADH oxidase and the mitochondrial electron transport between cytochromes b and c (13) (14) (15) (16) , which may result in O 2
•-production at the mitochondria. According to our data, the level of the intracellular O 2
•-was significantly increased in AMA-treated cells at the early or late times. This increase likely resulted from the production of O 2
•-at the mitochondria in AMA-treated Calu-6 cells rather than the decreased activity of SOD, since SOD activity was increased by treatment with AMA at 72 h. Although we cannot explain the exact mechanism resulting in AMA increasing SOD activity at 72 h, it is possible that O 2
•-production from mitochondria damaged by AMA triggers SOD expression and its activity. The O 2
•-levels of AMA markedly increased within 10 min in a dose-dependent manner. The increase of O 2
•-levels at the early time points was probably from the decreased activity of SOD as well as the production of O 2
•-at the mitochondria. These data suggest that the accumulation of O 2
•-levels due to the production of itself and/or changes of SOD activity is time-dependent. In particular, the increase of catalase activity by AMA at 1 h did not reduce intracellular ROS (DCF) levels, while the decreased activity of catalase at 72 h did not increase the ROS levels. Therefore, the changes of ROS levels in AMA-treated Calu-6 cells appear to be regulated by other factors such as SOD and GSH peroxidase rather than catalase. The increased O 2
•-levels by AMA were observed in human lung epithelial (40) and As4.1 juxtaglomerular cells (22) . These data suggest that the apoptotic effects of AMA are comparative to the changes of the intracellular O 2
•-levels. This notion was supported by the result that tiron, showing the reduction of the intracellular O 2
•-levels, slightly inhibited AMA-induced cell death. Trimetazidine, SOD or catalase showed no reduction of O 2
•-levels in AMA-treated cells and did not decrease apoptosis in these cells. However, tempol, another O 2
•-scavenger did not affect apoptotic levels in AMA-treated Calu-6 cells. We observed that caspase-3 and -8 inhibitors, which showed antiapoptotic effects on AMA-treated Calu-6 cells, did not significantly reduce O 2
•-levels (unpublished data). The exact cell death mechanism through intracellular O 2
•-in AMAtreated cells needs to be defined further.
Interestingly, tiron significantly prevented loss of the mitochondrial transmembrane potential (ΔΨ m ) while tempol, which showed the decreased effects on O 2
•-levels in AMAtreated cells, slightly prevented the loss (ΔΨ m ). Since it is known that tempol and tiron are SOD-mimics (33) (34) (35) , it is possible that tempol and tiron play a role in protecting mitochondria via scavenging the O 2
•-generated from mitochondria in AMA-treated cells rather than in preventing apoptosis resulting from entire cell damage by AMA. In addition, treatment with exogenous SOD or catalase significantly inhibited loss of the mitochondrial transmembrane potential (ΔΨ m ) induced by AMA. These results suggest the possibility that exogenous SOD and catalase scavenge the extracellular ROS released from AMA-treated cells, thereby blocking down the detrimental autocrine effects of ROS on mitochondria in these cells.
It has been reported that the intracellular GSH content has a decisive effect on anticancer drug-induced apoptosis, indicating that apoptotic effects are inversely comparative to GSH content (41, 42) . Similarly, our result clearly indicated the depletion of the intracellular GSH content following treatment with AMA in Calu-6 cells at 72 h. We have shown that many of the negative CMF fluorescence (GSH depletion) cells were considered to be dead, as evidenced by PI-positive staining. No effect of tempol, trimetazidine, SOD or catalase on preventing apoptosis in AMA-treated cells likely resulted from their failure of the recovery of GSH depletion. These results support that the intracellular GSH levels are tightly related to AMA-induced cell death. However, tiron which showed an anti-apoptotic effect in AMA-treated cells, also failed to recover the GSH depletion in these cells. These results suggest that AMA-induced Calu-6 cell death is mediated by ROS changes as well as GSH content alteration. In relation to the cell cycle distribution following treatment with AMA and ROS scavengers including SOD and catalase, ROS scavengers except tempol did not alter a G1 phase accumulation during the cell cycle induced by AMA (data not shown), suggesting that changes in ROS levels and GSH contents by these scavengers are not closely correlated with cell cycle regulation in Calu-6 cells.
In summary, AMA strongly generated intracellular O 2
•-
and induced the depletion of GSH content in human lung Calu-6 cells. Treatment with tiron showing the decreasing effect on O 2
•-levels in AMA-treated cells significantly prevented apoptosis in these cells. Our results suggest that the changes of intracellular ROS including O 2
•-and GSH affect apoptosis in AMA-treated Calu-6 cells.
